Perspective Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q2 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Perspective Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q2 2011 to Q3 2024.
  • Perspective Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending September 30, 2024 was $694K, a 26% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $694K +$143K +26% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $672K +$99K +17.3% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $482K -$85K -15% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $487K +$312K +178% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $551K +$450K +446% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $573K +$466K +436% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 $567K +$468K +473% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $175K +$65K +59.1% Dec 31, 2022 10-K 2024-03-28
Q3 2022 $101K -$19K -15.8% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $107K -$23K -17.7% Jun 30, 2022 10-KT 2023-05-01
Q1 2022 $99K -$18K -15.4% Mar 31, 2022 10-Q 2022-05-13
Q4 2021 $110K -$9K -7.56% Dec 31, 2021 10-Q 2022-02-09
Q3 2021 $120K -$8K -6.25% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $130K -$8K -5.8% Jun 30, 2021 10-KT 2023-05-01
Q1 2021 $117K -$16K -12% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $119K -$23K -16.2% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 $128K -$23K -15.2% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $138K -$24K -14.8% Jun 30, 2020 10-K 2021-09-27
Q1 2020 $133K -$27K -16.9% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $142K -$31K -17.9% Dec 31, 2019 10-Q 2020-02-12
Q3 2019 $151K -$34K -18.4% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $162K -$36K -18.2% Jun 30, 2019 10-K 2020-09-25
Q1 2019 $160K -$32K -16.7% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $173K -$31K -15.2% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 $185K -$32K -14.7% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $198K -$32K -13.9% Jun 30, 2018 10-K 2019-09-27
Q1 2018 $192K -$75K -28.1% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $204K -$74K -26.6% Dec 31, 2017 10-Q 2018-02-09
Q3 2017 $217K -$75K -25.7% Sep 30, 2017 10-Q 2017-11-14
Q2 2017 $230K +$79K +52.3% Jun 30, 2017 10-K 2018-09-26
Q1 2017 $267K +$44.5K +20% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $278K +$45K +19.3% Dec 31, 2016 10-Q 2017-02-09
Q3 2016 $292K +$51.6K +21.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $151K -$94K -38.4% Jun 30, 2016 10-K 2017-09-28
Q1 2016 $223K -$20.6K -8.49% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $233K -$17.9K -7.13% Dec 31, 2015 10-Q 2016-02-09
Q3 2015 $240K -$18.2K -7.05% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $245K -$19K -7.21% Jun 30, 2015 10-K 2016-09-09
Q1 2015 $243K -$15.5K -5.97% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $251K -$11.8K -4.49% Dec 31, 2014 10-Q 2015-02-17
Q3 2014 $259K -$12.8K -4.7% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 $264K -$12.4K -4.5% Jun 30, 2014 10-K 2015-09-14
Q1 2014 $259K -$35K -11.9% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 $263K -$38.4K -12.7% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 $271K -$30K -9.97% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $277K -$25.2K -8.35% Jun 30, 2013 10-K 2014-09-29
Q1 2013 $294K -$6.08K -2.03% Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $301K +$27.8K +10.2% Dec 31, 2012 10-Q 2013-02-14
Q3 2012 $301K +$22K +7.86% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $302K +$24.5K +8.84% Jun 30, 2012 10-K 2013-09-30
Q1 2012 $300K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $273K Dec 31, 2011 10-Q 2012-02-14
Q3 2011 $279K Sep 30, 2011 10-Q/A 2011-12-13
Q2 2011 $277K Jun 30, 2011 10-K/A 2012-10-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.